With second FDA approval, CAR-T’s transformative power multiplies With second FDA approval, CAR-T’s transformative power multiplies After last year’s approval to treat pediatric lymphoma, the latest indication will expand the number of patients that can be treated with personalized cell therapy almost tenfold.
The path through Penn Medicine The path through Penn Medicine Medical students can commiserate with each other over the experience of med school and share a level of empathy and understanding with one another. But the reality of being a med student is a unique experience for everyone. Two students who were profiled in their first and second years of training reflect on their third year at the Perelman School of Medicine.
Penn Medicine students to participate in first-ever citywide medical story slam Penn Medicine students to participate in first-ever citywide medical story slam Students will share experiences through five-minute stories at the May 7 event at the College of Physicians of Philadelphia.
Newly approved heart surgery procedure debuts at Penn Medicine Newly approved heart surgery procedure debuts at Penn Medicine The first surgery using high-resolution mapping of the heart successfully located areas of arrhythmia to eliminate.
Two faculty members elected to National Academy of Sciences Shelley Berger and Karen Goldberg Two faculty members elected to National Academy of Sciences Shelly Berger and Karen Goldberg are among 84 new members elected to the National Academy of Sciences, one of the highest honors for a scientist.
FDA approves CAR T therapy for large B-Cell lymphoma developed at Penn Manufactured CAR T cells FDA approves CAR T therapy for large B-Cell lymphoma developed at Penn The nation’s first approved personalized cellular therapy is now available for a second indication.
One-fifth of homeless youth are victims of human trafficking One-fifth of homeless youth are victims of human trafficking A new study highlights the pipeline from abuse to homelessness to sex trafficking among youth in Philadelphia, D.C., and Phoenix, the largest study to date on human trafficking and teens.
Healthy T cells have a fighting chance for cell therapy Healthy T cells have a fighting chance for cell therapy Patients with chronic lymphocytic leukemia (CLL) who have a healthy amount of T cells prior to treatment (“early memory” T cells) responded positively to CAR T therapy, highlighting a powerful biomarker for successful therapies for that specific type of leukemia.
A potential new weapon in the battle against addiction The green fluorescent ‘dots’ above show where Exendin-4, an FDA-approved drug used to treat diabetes and obesity, ends up in the brain. The drug activates receptors for glucagon-like peptide 1 or GLP-1, a hormone that reduces food intake. The blue and red coloring indicate neurons and astrocytes, respectively. A potential new weapon in the battle against addiction New research revealed that FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help addicts break the habit. Such medications work by targeting receptors for glucagon-like peptide 1, a hormone in the brain.
Teens might put their phones down while driving. For a price. Teens might put their phones down while driving. For a price. Researchers found that teen drivers are receptive to relinquishing some, but not all, mobile device habits, with the right incentives.